Loading resource…

ANGWECH ANNET
Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem cells characterized by chronic cytopenia and dysplasia, with a risk of progression to acute myeloid leukemia (AML). The document discusses the various subtypes of MDS, their epidemiology, risk factors, and clinical manifestations. It also addresses bone marrow failure diseases, including aplastic anemia, and outlines treatment options and supportive care measures.
No account needed